Form 8-K - Current report:
SEC Accession No. 0001437749-24-035033
Filing Date
2024-11-14
Accepted
2024-11-14 08:01:49
Documents
14
Period of Report
2024-11-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K wint20241113_8k.htm   iXBRL 8-K 41018
  Complete submission text file 0001437749-24-035033.txt   181375

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA wint-20241108.xsd EX-101.SCH 3411
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20241108_def.xml EX-101.DEF 11809
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20241108_lab.xml EX-101.LAB 15860
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20241108_pre.xml EX-101.PRE 12024
16 EXTRACTED XBRL INSTANCE DOCUMENT wint20241113_8k_htm.xml XML 2938
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

EIN.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39290 | Film No.: 241457297
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)